For laboratory research use only. Not for human or veterinary use. Read our research-use policy

Tissue biology

TB-500 research peptide

The name TB-500 is used by suppliers for a synthetic peptide related to thymosin beta-4; the supplier's COA states exactly which.

2 sizes · from $20.99 · 1 in stock · flat $24.95 US shipping per order

Sizes, prices and availability

TB-500 sizes and prices
SizeSKUStated purityBatch COAPriceAvailability
5 mg BT5 Not yet provided Not yet provided $20.99 Out of stock
10 mg OLY-TB500-10MG 99%+ (supplier) Not yet provided $34.99 In stock

Blend vials containing TB-500

Covalume also lists blend vials that contain TB-500 together with BPC-157.

Blend vials containing TB-500
SizeSKUStated purityBatch COAPriceAvailability
BPC-157 10mg + TB-500 10mg BB20 Not yet provided Not yet provided $53.99 In stock
BPC-157 5mg + TB-500 5mg BB10 Not yet provided Not yet provided $26.99 In stock

Prices and stock are checked at build time and refreshed live in your browser. Orders are US only for a flat $24.95 shipping fee. Shipping details

About TB-500

Thymosin beta-4 is a 43-amino-acid, actin-sequestering protein (Goldstein et al., 2005; Hannappel, 2007). TB-500 is the name suppliers use for a synthetic peptide derived from it; it is commonly described as the acetylated fragment Ac-LKKTETQ, which corresponds to residues 17 to 23 of thymosin beta-4 and contains its actin-binding motif.

Because TB-500 is not a standardised chemical name, identity matters: a vial labelled TB-500 may be the heptapeptide fragment or the full-length thymosin beta-4. The two have very different molecular weights (about 889 and about 4963 g/mol), and mass spectrometry on a batch certificate settles which one a given lot is. This is the type of check our guide to reading a Certificate of Analysis walks through.

What the published literature covers

  • Goldstein et al. (2005) review thymosin beta-4 as an actin-sequestering protein with additional roles in injured-tissue models.
  • Hannappel (2007) reviews the beta-thymosins.
  • Sosne et al. (2007) review thymosin beta-4 in corneal wound-healing and anti-inflammatory models.
  • Tham et al. (2026) review the investigational-peptide literature for BPC-157, thymosin beta-4 and TB-500.

Vial arithmetic for TB-500

Work out the concentration, syringe units per draw and draws per vial for any TB-500 vial size with our TB-500 reconstitution calculator, or the general peptide reconstitution calculator. To turn a volume into syringe units, use the syringe units converter or, for the blend vials, the peptide blend calculator. These tools do arithmetic only; they do not suggest any amount.

FAQ

Is TB-500 the same as thymosin beta-4?

Not necessarily. Thymosin beta-4 is a 43-amino-acid protein. TB-500 is a supplier name usually used for a synthetic fragment, commonly given as Ac-LKKTETQ (residues 17 to 23). The molecular weight on the mass-spectrometry result of a batch COA shows which one a lot contains.

What is the molecular formula of TB-500?

For the commonly cited fragment Ac-LKKTETQ, PubChem lists C38H68N10O14 (about 889 g/mol). Full-length thymosin beta-4 is C212H350N56O78S (about 4963 g/mol).

What sizes of TB-500 does Covalume list?

Covalume lists TB-500 in 2 sizes: 5 mg, 10 mg. Each size shows its price and live stock status in the variants table on this page.

How is the purity of TB-500 documented?

Each listing shows the purity the supplier states, labelled (supplier), and the batch Certificate of Analysis field reads "Not yet provided" until a batch-specific document is on file. Our guide to reading a Certificate of Analysis explains what HPLC and mass-spectrometry results show.

References

  1. Goldstein AL, Hannappel E, Kleinman HK (2005). Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med 11:421-9. PubMed 16099219 · DOI
  2. Hannappel E (2007). beta-Thymosins. Ann N Y Acad Sci 1112:21-37. PubMed 17468232 · DOI
  3. Sosne G, Qiu P, Kurpakus-Wheater M (2007). Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent. Clin Ophthalmol 1:201-7. PubMed 19668473
  4. Tham A, Hodgkins CW, Kennedy JG (2026). Investigational Peptides in Orthopaedic Practice: Evidence, Safety, and Patient Counseling for BPC-157, Thymosin Beta-4, and TB-500. J Am Acad Orthop Surg. PubMed 42937313 · DOI

Identity values are from PubChem (CID 62707662) and the cited papers; for linear peptides the mass was also checked against the sequence. Last updated 2026-11-18.

Related research peptides

From the research library